Please Wait

Applying Filters...

Nadroparin
USDMF
Table View

CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Nadroparin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 10 USDMF, 6 JDMF, 1 EU WC, 1 KDMF, 7 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

131 FDF Dossiers, 15 FDA Orange Book, 77 Europe, 21 Canada, 11 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;SUBCUTANEOUS - 10,000IU/ML (10,000IU/ML), INJECTABLE;SUBCUTANEOUS - 10,000IU/4ML (2,500IU/ML), INJECTABLE;SUBCUTANEOUS - 12,500IU/0.5ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 15,000IU/0.6ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 18,000IU/0.72ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 2,500IU/0.2ML (12,500IU/ML), INJECTABLE;SUBCUTANEOUS - 5,000IU/0.2ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 7,500IU/0.3ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 95,000IU/3.8ML (25,000IU/ML)

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 3 Actylis, 1 Finar

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Topical, 1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 3 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

16 APIs, 43 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Sanofi	France	SANOFI SYNTHELABO INC	9939	NADROPARIN CALCIUM	1992-11-02	Inactive	II	N/A
28/03/2025	ALP Pharm	China	ALP PHARM BEIJING CO LTD	21950	DALTEPARIN SODIUM (DRUG SUBSTANCE, NON-STERILE)	2008-09-01	Inactive	II	N/A

Contact us
to update this info

Nadroparin

Nadroparin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers

10 USDMF

6 JDMF

1 EU WC

1 KDMF

7 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

131 FDF Dossiers

15 FDA Orange Book

77 Europe

21 Canada

11 South Africa

7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;SUBCUTANEOUS - 10,000IU/ML (10,000IU/ML)

INJECTABLE;SUBCUTANEOUS - 10,000IU/4ML (2,500IU/ML)

INJECTABLE;SUBCUTANEOUS - 12,500IU/0.5ML (25,000IU/ML)

INJECTABLE;SUBCUTANEOUS - 15,000IU/0.6ML (25,000IU/ML)

INJECTABLE;SUBCUTANEOUS - 18,000IU/0.72ML (25,000IU/ML)

INJECTABLE;SUBCUTANEOUS - 2,500IU/0.2ML (12,500IU/ML)

INJECTABLE;SUBCUTANEOUS - 5,000IU/0.2ML (25,000IU/ML)

INJECTABLE;SUBCUTANEOUS - 7,500IU/0.3ML (25,000IU/ML)

INJECTABLE;SUBCUTANEOUS - 95,000IU/3.8ML (25,000IU/ML)

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical

3 Actylis

1 Finar

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Topical

1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

46 Regulatory FDF Prices

5 Annual Reports

MARKET PLACE

16 APIs

43 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

1 USP

1 Others

Filters